COSMO Pharmaceuticals SA (0RGI) — Capital Reinvestment Ratio

Latest as of June 2025: 2.92x

COSMO Pharmaceuticals SA (0RGI) has a Capital Reinvestment Ratio of 2.92x as of June 2025, meaning it reinvests 3% of its operating cash flow (£900.00K) in capital expenditures (£2.62 Million). See 0RGI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.92x
Capex / Operating Cash Flow

Operating Cash Flow

£900.00K
GBP

Capital Expenditures

£2.62 Million
GBP

Data as of

Jun 2025
Most recent filing

COSMO Pharmaceuticals SA Capital Reinvestment Ratio (2004–2024)

This chart tracks COSMO Pharmaceuticals SA's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for COSMO Pharmaceuticals SA (2004–2024)

Year-by-year Capital Reinvestment Ratio for COSMO Pharmaceuticals SA from 2004 to 2024. For live market cap and broader valuation context, see COSMO Pharmaceuticals SA (0RGI) market capitalisation.

Year Reinvestment Ratio Operating CF (GBP) Capital Expenditures YoY Change
2024 0.03x £162.41 Million £5.65 Million ▼ -82.0%
2023 0.19x £22.71 Million £4.40 Million ▲ +42.4%
2022 0.14x £32.89 Million £4.47 Million ▼ -79.8%
2021 0.67x £12.61 Million £8.50 Million ▲ +8.3%
2020 0.62x £12.98 Million £8.09 Million ▼ -10.8%
2016 0.70x £26.41 Million £18.43 Million ▲ +1747.0%
2014 0.04x £66.45 Million £2.51 Million ▼ -88.8%
2013 0.34x £8.11 Million £2.73 Million ▲ +154.8%
2012 0.13x £23.00 Million £3.04 Million ▼ -55.8%
2011 0.30x £11.29 Million £3.37 Million ▼ -68.7%
2010 0.95x £7.79 Million £7.42 Million ▼ -45.0%
2009 1.73x £3.88 Million £6.72 Million ▲ +30.1%
2006 1.33x £6.08 Million £8.10 Million ▼ -46.1%
2005 2.47x £1.70 Million £4.20 Million ▼ -73.6%
2004 9.36x £261.00K £2.44 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow